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COMMENTARY Open Access
The heart of the matter: in search of causal
effects of depression on somatic diseases
Annelieke M. Roest and Peter de Jonge*
Abstract
The question of whether depression is a causal factor in somatic diseases remains unanswered despite decades of
research. In an extensive umbrella review of systematic reviews and meta-analyses, Machado et al. (BMC Medicine
16:112, 2018) found significant associations between depression and all-cause and cause-specific mortality.
However, as the authors clearly argued, these results do not prove causation. The next logical step is to study the
potential effect of depression and other mental disorders by placing emphasis on temporality (associations over
time) and specificity (unique associations) of associations between a comprehensive set of mental disorders and
somatic diseases. A data-driven approach in large samples could uncover disease development trajectories to
provide a route for researchers and clinicians to improve medical outcomes in vulnerable patient groups.
Background
Depression is a major health problem, being among the
top five causes of burden of disease in Europe and North
America according to the Global Burden of Disease
study [1]. This hierarchical list of diseases is based on
disability-adjusted life years, namely years of life lost due
to premature mortality and years lived with disability, at-
tributed to all diseases. Since only direct causes of death
are taken into account, with suicides coded under injur-
ies, the high ranking of depression is solely due to the
high number of years lived with disability. Yet, if depres-
sion also affects mortality by causing other diseases, the
Global Burden of Disease study estimates for depression,
and mental disorders in general, significantly underesti-
mate the burden attributable to these disorders.
Depression as a potential cause of all-cause and cause-
specific mortality
Many studies have described the putative association be-
tween depression and mortality; while the association is
most obvious in the case of completed suicide, a substan-
tial amount of research has shown the possibility that de-
pression increases the risk of somatic diseases, thereby
indirectly leading to death. In their work in BMC Medi-
cine, Machado et al. [2] provide a comprehensive umbrella
review on systematic reviews and meta-analyses examin-
ing the association between depression and all-cause and
cause-specific mortality, confirming the positive associa-
tions that have been previously reported for all included
causes of mortality. However, the authors warn against
concluding that these associations are causal, given that
the strength of the evidence was reduced to ‘suggestive’
when considering only studies that examined depressive
disorder (instead of depressive symptoms) or that
accounted for potential confounders. Their paper shows
that the question of whether the association between de-
pression and mortality is causal is an important topic, yet,
after decades of research, it remains unanswered at best.
Intervention trials
Ultimate proof for a causal association between depression
and somatic diseases could be provided by randomized
controlled trials in which medical outcomes, e.g., survival,
are positively influenced by treating depression. This type
of trial has been conducted in specific patient samples
such as individuals with cardiac disease; nevertheless,
these trials led to disappointing results as no effects of
antidepressant treatment on cardiac outcomes have been
observed (e.g. [3, 4]). However, in secondary analyses, such
as in subgroups of participants for example, positive re-
sults have been obtained [5]. In addition, several studies
have suggested potential explanations for the negative
findings, including treatment resistance of specific (som-
atic/affective) depressive symptoms [6, 7]. Although it
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could be argued that the development of interventions for
these persistent depressive symptoms could improve the
medical prognosis of patients with cardiac disease [7],
confounding by somatic disease processes may also be a
reasonable explanation of these results.
Specific and temporal associations
Other approaches that can be taken to examine the like-
lihood of causality is to assess the specificity of associa-
tions and temporal associations between diseases [8].
Machado et al. [2] took an important step regarding the
specificity of the effect of depression by examining
all-cause and cause-specific mortality in different popu-
lations such as in patients with cancer or heart failure.
Specific associations between depression and outcomes
could suggest causal effects, yet the authors did not find
particularly strong associations for any of the specific
diseases [2]. However, it can be questioned whether
mechanisms linking depression to somatic diseases are
in fact specific since suggested pathways include general
mechanisms, such as inflammatory processes and health
behaviors, linked to various somatic diseases. In that re-
spect, it is also important to note that studies on the as-
sociation between depression and somatic diseases in
general try to control for health behaviors in the best
possible way (e.g., [9]). However, health behavior factors,
such as smoking, alcohol use, body mass index, and
physical inactivity, could also be potential mediators of
the association, thereby underestimating the strength of
the effects.
Another important factor is the temporality, or order, of
the associations. Depression predicts the development of
somatic diseases, but these somatic diseases in turn also
predict depression. Associations between depression and
potential mediating mechanisms, e.g., obesity [10] and
physical activity [11], are also bidirectional in nature. Fur-
ther, although mechanisms are usually studied in isolation,
they are in fact closely related, e.g., inflammatory markers
and body mass index. Taking a temporal approach in
examining the association between depression, other men-
tal disorders, potential mediating mechanisms, and som-
atic diseases can provide greater insight of potential causal
associations between these factors. For example, anxiety
disorders precede depression in the majority of cases and
could therefore, in principle, explain part of the effect of
depression on somatic diseases. Additionally, factors oc-
curring even earlier in life, including a genetic predispos-
ition for both depression and somatic diseases (e.g., by a
shared genetic substrate for depression and autonomic
dysfunction [12]), could be the driving factor.
Steps to take
Research on temporality and specificity should now pro-
gress by taking multiple somatic diseases and mental
disorders into account instead of limiting analyses to
one outcome such as cancer or heart disease. A data-
driven approach could be used to examine temporal and
specific associations between depression, other mental
disorders, somatic diseases, and mortality. For example,
a study that applied this approach by examining tem-
poral associations between disease diagnoses (mainly
somatic) retrieved from electronic health registries cov-
ering large numbers of individuals found that gout plays
a central role in the progression of cardiovascular dis-
eases and highlighted the important role of retinal disor-
ders as a marker of disease progression in individuals
with diabetes [13]. Disease trajectories may also differ
between individuals, information that could be used to
identify those at risk for a specific outcome. For
example, a study on risk of sepsis mortality found that
different trajectories, with three major starting points,
namely cardiovascular disease, diabetes, and alcohol
abuse, led to such an outcome [14].
Conclusion
It is time to move forward from studying the association
between one mental disorder and one somatic disease.
These studies are unlikely to provide definitive answers
since reality is much more complex. Instead, the tem-
poral order of multiple mental disorders and somatic
diseases, ideally including the mediating mechanisms,
should be examined in concert. Findings from these
studies could demonstrate linkages between specific dis-
eases for which previous results have been inconclusive.
Furthermore, trajectories that may be suggestive of spe-
cific disease development patterns could be uncovered.
However, these studies in themselves are not capable of
proving causality per se, but may provide persuasive re-
sults on the actual burden of disease resulting from de-
pression and other mental disorders as well as important
suggestions on when and how to intervene to reduce
this burden.
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